Fermented Soymilk with Probiotic Lactobacilli and Bifidobacterium Strains Ameliorates Dextran-Sulfate-Sodium-Induced Colitis in Rats
Nutrients · 14.10.2024 · 16 (20) · 3478
DOI: 10.3390/nu16203478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 14.10.2024. Verfasst von Ashwag Jaman Al Zahrani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Department of Biological Sciences, University of Jeddah, Jeddah 21959, Saudi Arabia. Hauptthemen laut MEDLINE: Probiotics, Soy Milk, Dextran Sulfate, Colitis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdulaziz University.
Abstract (Originalsprache)
Background
Current treatments for inflammatory bowel disease (IBD) are relatively futile and the extended use of drugs may reduce effectiveness. Several probiotic strains have shown promise in relieving/treating IBD symptoms.
Objectives
The current study investigated the impact of fermented soymilk with a mixture of probiotic starter cultures containing Lactobacillus rhamnosus, L. casei, L. plantarum, L. acidophilus, Bifidobacterium longum, and B. animalis subsp. lactis in rats with dextran sulfate sodium (DSS)-induced colitis compared to control.
Methods
Rats were randomly assigned to five groups (5 rats/group; n = 25): G1: negative normal control; G2: positive control (DSS); G3: DSS with sulfasalazine (DSS-Z); G4: DSS with soymilk (DSS-SM), and G5: DSS with fermented soymilk (DSS-FSM). Parameters monitored included the following: the disease activity index (DAI), macroscopic and histological assessments of colitis, and a fecal microbial analysis performed to assess the severity of inflammation and ulceration.
Results
The DSS-FSM rats group exhibited lower DAI scores (p < 0.05) than other treated groups during the induction period. A macroscopical examination revealed no ulceration or swelling in the intestinal mucosa of rats in the DSS-FSM-treated group, resembling the findings in the negative control group. In the positive control (DSS group), the colon tissue showed increased inflammation (p < 0.05), whereas those in the DSS-SM- and DSS-FSM-treated rats groups did not show significant macroscopic scores of colitis. The positive DSS control and DSS-Z groups had crypt erosion and ulceration areas, severe crypt damage, and epithelial surface erosion, which were absent in the negative control and DSS-FSM groups. The counts of Lactobacillus spp. and Bifidobacterium spp. remained stable in both G1 and G5 over 4 weeks. The consumption of fermented soymilk with a mixture of probiotics could minimize the severity of DSS-induced colitis in rats. Conclusion, it was found that fermented soymilk containing Lactobacilli and Bifidobacterium might be an effective vehicle for reducing the severity of DSS-induced colitis in rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science, Department of Biological Sciences, University of Jeddah, Jeddah 21959, Saudi Arabia.
- Faculty of Science, Department of Biological Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Förderung
- King Abdulaziz University
Zitieren
APA
Al Zahrani, A. J., Shori, A. B., & Al-Judaibi, E. (2024). Fermented Soymilk with Probiotic Lactobacilli and Bifidobacterium Strains Ameliorates Dextran-Sulfate-Sodium-Induced Colitis in Rats. Nutrients, 16(20), 3478. https://doi.org/10.3390/nu16203478
Vancouver
Al Zahrani AJ, Shori AB, Al-Judaibi E. Fermented Soymilk with Probiotic Lactobacilli and Bifidobacterium Strains Ameliorates Dextran-Sulfate-Sodium-Induced Colitis in Rats. Nutrients. 2024;16(20):3478. doi:10.3390/nu16203478
BibTeX
@article{AlZahrani2024,
author = {Al Zahrani, Ashwag Jaman and Shori, Amal Bakr and Al-Judaibi, Effat},
title = {Fermented Soymilk with Probiotic Lactobacilli and Bifidobacterium Strains Ameliorates Dextran-Sulfate-Sodium-Induced Colitis in Rats},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {20},
pages = {3478},
doi = {10.3390/nu16203478}
}
EUVIMED